Serious food-borne illness cases (Salmonella, Listeria, E. coli O157:H7, Cyclospora) generate genuine product-liability claims when a contaminated product sickened the plaintiff and the defendant knew or should have known of a contamination risk that was not controlled. These are not consumer complaint cases. At the severity level that warrants PI litigation, we are talking about hemolytic uremic syndrome and kidney failure, miscarriage or stillbirth from Listeria, or a hospitalization that resulted in permanent neurological damage. Building that case requires matching the contamination source to the defendant's supply chain failure and surviving a causation fight that will be hard-contested by sophisticated food industry defense counsel.
The FSMA Framework and What It Creates for Plaintiff Litigation
The Food Safety Modernization Act (FSMA), signed in 2011 and phased in over the following decade, created mandatory preventive control requirements for most food manufacturers and produce growers. FSMA rules require hazard analysis and risk-based preventive controls, environmental monitoring programs for pathogens in ready-to-eat food facilities, and written food safety plans. Unlike prior FDA guidance, FSMA standards are enforceable regulations with the force of law.
For plaintiff counsel, FSMA's primary value is as a source of negligence per se arguments. A food manufacturer whose written hazard analysis failed to identify Listeria contamination in a ready-to-eat environment, or whose environmental monitoring program was not conducted at the required frequency, has violated a federal regulation with safety-protective intent. That violation, if causally connected to the contamination event, supports a negligence per se instruction in a growing number of jurisdictions. Equally important, the manufacturer's own FSMA compliance records are discoverable and frequently show the gaps in the hazard control program that preceded the outbreak.
Defendant Identification: The Chain From Farm to Consumer
A packaged produce contamination case may involve the following potential defendants:
- The grower or farm operation, where inadequate field sanitation, contaminated irrigation water, or proximity to concentrated animal feeding operations allowed pathogen entry at the source.
- The packer or processor, where post-harvest washing or processing conditions allowed cross-contamination, inadequate sanitizer concentration, or recontamination from an environmental source.
- The co-packer or private-label manufacturer, where the retailer's brand is applied to product processed under contract and the contract terms determine which party bore food safety responsibility.
- The distributor, where cold-chain temperature deviations during transit created conditions for pathogen growth.
- The retailer, under its own independent duty to inspect and not sell product that has been recalled or that showed signs of spoilage.
In most contaminated food cases, the most financially viable defendant is the manufacturer or processor rather than the grower. Growers often carry limited insurance relative to the potential damages in a serious illness case, and their operations may not be subject to FSMA preventive control requirements if they are a qualifying small farm. The processor who received the raw material, handled it in a ready-to-eat facility, and packaged it under its brand is both the party with regulatory obligations and the party most likely to carry adequate insurance.
Causation: The Two-Part Challenge
Contaminated food causation proof requires two separate expert opinions that must both survive a Daubert challenge: (1) that the plaintiff's illness was caused by the specific pathogen identified in the outbreak, and (2) that the defendant's product was the source of the plaintiff's exposure to that pathogen.
On the first element, an infectious disease physician expert reviews the plaintiff's lab records, clinical presentation, timing of symptom onset, and incubation period for the organism to establish that the plaintiff's illness is consistent with infection by the outbreak pathogen. Where the plaintiff's pathogen was typed by whole-genome sequencing (WGS) and matches the outbreak strain in the CDC cluster, the epidemiological connection is far stronger than cases relying on serotype matching alone.
On the second element, epidemiological causation depends heavily on whether the plaintiff's product lot can be linked to the contaminated batch identified in any FDA or CDC traceback investigation. Key discovery targets include:
- The plaintiff's purchasing records, loyalty card data, or food diary establishing product consumption before onset of illness.
- The manufacturer's lot code and production date records matching the product batch the plaintiff purchased.
- FDA inspection records and Form 483 observations issued to the facility during or after the outbreak investigation.
- Any WGS-confirmed pathogen isolates from the production environment matching the outbreak strain, which link the contamination source to the defendant's facility.
The Recall as Evidence and Its Limitations
A voluntary or mandatory recall of the product the plaintiff consumed is powerful but not dispositive evidence. Defense counsel will argue that the recall establishes only that the manufacturer had reason to believe a product may be contaminated; not that the specific unit the plaintiff consumed was. The response is to use the recall announcement, the lot codes affected, and any confirmatory positive environmental tests to narrow the contamination probability to the specific lot, and to retain a food safety expert who can model the contamination likelihood for that lot based on the facility's environmental monitoring data.
Under Federal Rule of Evidence 407 (subsequent remedial measures), post-incident facility improvements may face admissibility challenges, but the recall itself and any regulatory correspondence associated with it generally does not qualify as a subsequent remedial measure. The FDA's records of its investigation are public-record materials obtainable through FOIA requests that fall outside Rule 407's scope entirely.
For additional product-liability resources including design defect and warning defect theory, see product-liability practice resources. Where the plaintiff's illness resulted in wrongful death, damages analysis for survivors is addressed at wrongful-death practice resources.